{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:40:55Z","timestamp":1788489655239,"version":"build-2803163510"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11064-020-03187-9","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T10:04:41Z","timestamp":1609841081000},"page":"425-438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Is Gut Dysbiosis an Epicenter of Parkinson\u2019s Disease?"],"prefix":"10.1007","volume":"46","author":[{"given":"Charul","family":"Rajput","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alika","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Sachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-6381","authenticated-orcid":false,"given":"Mahendra Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"3187_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/bmj.k2179","volume":"361","author":"AM Valdes","year":"2018","unstructured":"Valdes AM, Walter J, Segal E, Spector TD (2018) Role of the gut microbiota in nutrition and health. BMJ 361:36\u201344. https:\/\/doi.org\/10.1136\/bmj.k2179","journal-title":"BMJ"},{"key":"3187_CR2","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","volume":"474","author":"E Thursby","year":"2017","unstructured":"Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474:1823\u20131836. https:\/\/doi.org\/10.1042\/BCJ20160510","journal-title":"Biochem J"},{"issue":"7122","key":"3187_CR3","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/4441022a","volume":"444","author":"RE Ley","year":"2006","unstructured":"Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Human gut microbes associated with obesity. Nature 444(7122):1022\u20131023. https:\/\/doi.org\/10.1038\/4441022a","journal-title":"Nature"},{"key":"3187_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fnagi.2017.00441","volume":"9","author":"X Yang","year":"2018","unstructured":"Yang X, Qian Y, Xu S, Song Y, Xiao Q (2018) Longitudinal analysis of fecal microbiome and pathologic processes in a rotenone induced mice model of Parkinson\u2019s disease. Front in Aging Neurosci 9:441. https:\/\/doi.org\/10.3389\/fnagi.2017.00441","journal-title":"Front in Aging Neurosci"},{"key":"3187_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fped.2015.00017","volume":"3","author":"EC Gritz","year":"2015","unstructured":"Gritz EC, Bhandari V (2015) The human neonatal gut microbiome: a brief review. Front Pediatr 3:17. https:\/\/doi.org\/10.3389\/fped.2015.00017","journal-title":"Front Pediatr"},{"key":"3187_CR6","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3389\/fneur.2019.01155","volume":"10","author":"D Yang","year":"2019","unstructured":"Yang D, Zhao D, Ali Shah SZ, Wu W, Lai M, Zhang X, Li J, Guan Z, Zhao H, Li W, Gao H, Zhou X, Yang L (2019) The role of the gut microbiota in the pathogenesis of Parkinson\u2019s disease. Front Neurol 10:1155. https:\/\/doi.org\/10.3389\/fneur.2019.01155","journal-title":"Front Neurol"},{"issue":"10","key":"3187_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrgastro.2012.156","volume":"9","author":"HJ Flint","year":"2012","unstructured":"Flint HJ, Scott KP, Louis P, Duncan SH (2012) The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 9(10):577\u2013589. https:\/\/doi.org\/10.1038\/nrgastro.2012.156","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3187_CR8","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1136\/gutjnl-2013-306541","volume":"63","author":"SF Clarke","year":"2014","unstructured":"Clarke SF, Murphy EF, O\u2019Sullivan O, Lucey AJ, Humphreys M, Hogan A, Hayes P, O\u2019Reilly M, Jeffery IB, Wood-Martin R, Kerins DM, Quigley E, Ross RP, O\u2019Toole PW, Molloy MG, Falvey E, Shanahan F, Cotter PD (2014) Exercise and associated dietary extremes impact on gut microbial diversity. Gut 63:1913\u20131920. https:\/\/doi.org\/10.1136\/gutjnl-2013-306541","journal-title":"Gut"},{"issue":"1","key":"3187_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, Mele MC (2019) What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet and diseases. Microorganisms 7(1):14. https:\/\/doi.org\/10.3390\/microorganisms7010014","journal-title":"Microorganisms"},{"issue":"4","key":"3187_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.12938\/bmfh.19-002","volume":"38","author":"G Uyar","year":"2019","unstructured":"Uyar G, Yildiran H (2019) A nutritional approach to microbiota in Parkinson\u2019s disease. Biosci Microbiota Food Health 38(4):115\u2013127. https:\/\/doi.org\/10.12938\/bmfh.19-002","journal-title":"Biosci Microbiota Food Health"},{"issue":"2","key":"3187_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.mib.2013.03.009","volume":"16","author":"A Khosravi","year":"2013","unstructured":"Khosravi A, Mazmanian SK (2013) Disruption of the gut microbiome as a risk factor for microbial infections. Curr Opin Microbiol 16(2):221\u2013227. https:\/\/doi.org\/10.1016\/j.mib.2013.03.009","journal-title":"Curr Opin Microbiol"},{"issue":"7","key":"3187_CR12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ni.2640","volume":"14","author":"JR Brestoff","year":"2013","unstructured":"Brestoff JR, Artis D (2013) Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol 14(7):676\u2013684. https:\/\/doi.org\/10.1038\/ni.2640","journal-title":"Nat Immunol"},{"issue":"1","key":"3187_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1017\/s1751731114002584","volume":"9","author":"R Ducatelle","year":"2014","unstructured":"Ducatelle R, Eeckhaut V, Haesebrouck F, Van Immerseel F (2014) A review on prebiotics and probiotics for the control of dysbiosis: present status and future perspectives. Animal 9(1):43\u201348. https:\/\/doi.org\/10.1017\/s1751731114002584","journal-title":"Animal"},{"issue":"37","key":"3187_CR14","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","volume":"21","author":"A Mulak","year":"2015","unstructured":"Mulak A, Bonaz B (2015) Brain-gut-microbiota axis in Parkinson\u2019s disease. World J Gastroenterol 21(37):10609\u201310620. https:\/\/doi.org\/10.3748\/wjg.v21.i37.10609","journal-title":"World J Gastroenterol"},{"issue":"5","key":"3187_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.tem.2018.02.006","volume":"29","author":"SM Ostojic","year":"2018","unstructured":"Ostojic SM (2018) Inadequate production of H2 by gut microbiota and Parkinson disease. Trends Endocrinol Metab 29(5):286\u2013288. https:\/\/doi.org\/10.1016\/j.tem.2018.02.006","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"3187_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13024-018-0304-2","volume":"14","author":"Y Shao","year":"2019","unstructured":"Shao Y, Le W (2019) Recent advances and perspectives of metabolomics-based investigations in Parkinson\u2019s disease. Mol Neurodegener 14(1):3. https:\/\/doi.org\/10.1186\/s13024-018-0304-2","journal-title":"Mol Neurodegener"},{"issue":"6","key":"3187_CR17","first-page":"1767","volume":"3","author":"BP Deepa, Singh","year":"2015","unstructured":"Deepa, Singh BP (2015) Critical analysis of Kampavata (Parkinsonism). Int Ayur Med J 3(6):1767\u20131773. http:\/\/www.iamj.in\/posts\/images\/upload\/1767_1773_1.pdf","journal-title":"Int Ayur Med J"},{"key":"3187_CR18","first-page":"1","volume-title":"Holistic approaches to infectious diseases","author":"S Westfall","year":"2017","unstructured":"Westfall S, Pratap S (2017) The Ayurvedic treatment of neurodegenerative diseases. In: Holistic approaches to infectious diseases. Apple Academic Press, Florida, pp\u00a01\u201338"},{"issue":"1","key":"3187_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/kleuhsj.kleuhsj_77_18","volume":"12","author":"SB Gupta","year":"2019","unstructured":"Gupta SB, Shindhe PS, Hiremath RR (2019) Evaluation of effect of kalyanakakshara in vibandha with special reference to constipation: an open clinical trial. Indian J Health Sci Biomed Res 12(1):44\u201349. https:\/\/doi.org\/10.4103\/kleuhsj.kleuhsj_77_18","journal-title":"Indian J Health Sci Biomed Res"},{"issue":"4","key":"3187_CR20","first-page":"311","volume":"4","author":"VG Rao","year":"2019","unstructured":"Rao VG, Jayraj R (2019) A glimpse into the pathology of Parkinson\u2019s disease-an Ayurvedic perspective. J Ayurveda Integr Med 4(4):311\u2013319. http:\/\/www.jaims.in\/index.php\/jaims\/article\/view\/905","journal-title":"J Ayurveda Integr Med"},{"issue":"1","key":"3187_CR21","doi-asserted-by":"publisher","first-page":"1542921","DOI":"10.1080\/16512235.2018.1542921","volume":"29","author":"I Miller","year":"2018","unstructured":"Miller I (2018) The gut\u2013brain axis: historical reflections. Microb Ecol Health Dis 29(1):1542921. https:\/\/doi.org\/10.1080\/16512235.2018.1542921","journal-title":"Microb Ecol Health Dis"},{"issue":"4","key":"3187_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1353-8020(01)00052-9","volume":"8","author":"MF Siddiqui","year":"2002","unstructured":"Siddiqui MF, Rast S, Lynn MJ, Auchus AP, Pfeiffer RF (2002) Autonomic dysfunction in Parkinson\u2019s disease: a comprehensive symptom survey. Parkinsonism Relat Disord 8(4):277\u2013284. https:\/\/doi.org\/10.1016\/S1353-8020(01)00052-9","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"3187_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.parkreldis.2007.09.002","volume":"14","author":"SM Cheon","year":"2008","unstructured":"Cheon SM, Ha MS, Park MJ, Kim JW (2008) Nonmotor symptoms of Parkinson\u2019s disease: prevalence and awareness of patients and families. Parkinsonism Relat Disord 14(4):286\u2013290. https:\/\/doi.org\/10.1016\/j.parkreldis.2007.09.002","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"3187_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmgh.2018.04.003","volume":"6","author":"CR Martin","year":"2018","unstructured":"Martin CR, Osadchiy V, Kalani A, Mayer EA (2018) The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol 6(2):133\u2013148. https:\/\/doi.org\/10.1016\/j.jcmgh.2018.04.003","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"6","key":"3187_CR25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Del Tredici K, Braak H (2007) Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33(6):599\u2013614. https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00874.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"3187_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1017\/S0317167100013202","volume":"39","author":"D Salat-Foix","year":"2012","unstructured":"Salat-Foix D, Tran K, Ranawaya R, Meddings J, Suchowersky O (2012) Increased intestinal permeability and Parkinson disease patients: chicken or egg? Can J Neurol Sci 39(2):185\u2013188. https:\/\/doi.org\/10.1017\/S0317167100013202","journal-title":"Can J Neurol Sci"},{"issue":"12","key":"3187_CR27","doi-asserted-by":"publisher","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB, Keshavarzian A (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PloS One 6(12):e28032. https:\/\/doi.org\/10.1371\/journal.pone.0028032","journal-title":"PloS One"},{"issue":"1","key":"3187_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-015-0196-0","volume":"3","author":"T Clairembault","year":"2015","unstructured":"Clairembault T, Leclair-Visonneau L, Coron E, Bourreille A, Le Dily S, Vavasseur F, Heymann MF, Neunlist M, Derkinderen P (2015) Structural alterations of the intestinal epithelial barrier in Parkinson\u2019s disease. Acta Neuropathol Commun 3(1):12. https:\/\/doi.org\/10.1186\/s40478-015-0196-0","journal-title":"Acta Neuropathol Commun"},{"key":"3187_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2016.09.003","volume":"285","author":"WL Kuan","year":"2016","unstructured":"Kuan WL, Bennett N, He X, Skepper JN, Martynyuk N, Wijeyekoon R, Moghe PV, Williams-Gray CH, Barker RA (2016) \u03b1-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function. Exp Neurol 285:72\u201381. https:\/\/doi.org\/10.1016\/j.expneurol.2016.09.003","journal-title":"Exp Neurol"},{"key":"3187_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","volume":"50","author":"D Devos","year":"2013","unstructured":"Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H, Coron E, des Varannes SB, Naveilhan P, Nguyen JM, Neunlist M, Derkinderen P (2013) Colonic inflammation in Parkinson\u2019s disease. Neurobiol Dis 50:42\u201348. https:\/\/doi.org\/10.1016\/j.nbd.2012.09.007","journal-title":"Neurobiol Dis"},{"issue":"5","key":"3187_CR31","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak H, R\u00fcb U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110(5):517\u2013536. https:\/\/doi.org\/10.1007\/s00702-002-0808-2","journal-title":"J Neural Transm"},{"issue":"4","key":"3187_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, Shen C, Lee H, Kulkarni S, Pasricha PJ, Lee G, Pomper MG, Dawson VL, Dawson TM, Ko SH (2019) Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103(4):627\u2013641. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.035","journal-title":"Neuron"},{"issue":"6","key":"3187_CR33","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.25020","volume":"27","author":"KM Shannon","year":"2012","unstructured":"Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH (2012) Is alpha-synuclein in the colon a biomarker for premotor Parkinson\u2019s disease? Evidence from 3 cases? Mov Disord 27(6):716\u2013719. https:\/\/doi.org\/10.1002\/mds.25020","journal-title":"Mov Disord"},{"issue":"6","key":"3187_CR34","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bj\u00f6rklund T, Wang ZY, Roybon L, Melki R, Li JY (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128(6):805\u2013820. https:\/\/doi.org\/10.1007\/s00401-014-1343-6","journal-title":"Acta Neuropathol"},{"issue":"12","key":"3187_CR35","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/mds.25135","volume":"27","author":"JP Bolam","year":"2012","unstructured":"Bolam JP, Pissadaki EK (2012) Living on the edge with too many mouths to feed: why dopamine neurons die. Mov Disord 27(12):1478\u20131483. https:\/\/doi.org\/10.1002\/mds.25135","journal-title":"Mov Disord"},{"issue":"1","key":"3187_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep33117","volume":"6","author":"AS Baumuratov","year":"2016","unstructured":"Baumuratov AS, Antony PM, Ostaszewski M, He F, Salamanca L, Antunes L, Weber J, Longhino L, Derkinderen P, Koopman WJH, Diederich NJ (2016) Enteric neurons from Parkinson\u2019s disease patients display ex vivo aberrations in mitochondrial structure. Sci Rep 6(1):1\u20132. https:\/\/doi.org\/10.1038\/srep33117","journal-title":"Sci Rep"},{"issue":"11","key":"3187_CR37","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","volume":"60","author":"W Li","year":"2017","unstructured":"Li W, Wu X, Hu X, Wang T, Liang S, Duan Y, Jin F, Qin B (2017) Structural changes of gut microbiota in Parkinson\u2019s disease and its correlation with clinical features. Sci China Life Sci 60(11):1223\u20131233. https:\/\/doi.org\/10.1007\/s11427-016-9001-4","journal-title":"Sci China Life Sci"},{"issue":"8","key":"3187_CR38","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/mdc3.12840","volume":"6","author":"C Bullich","year":"2019","unstructured":"Bullich C, Keshavarzian A, Garssen J, Kraneveld A, Perez-Pardo P (2019) Gut vibes in Parkinson\u2019s disease: the microbiota-gut-brain axis. Mov Disord Clin Pract 6(8):639\u2013651. https:\/\/doi.org\/10.1002\/mdc3.12840","journal-title":"Mov Disord Clin Pract"},{"key":"3187_CR39","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fneur.2019.00574","volume":"10","author":"SF Santos","year":"2019","unstructured":"Santos SF, de Oliveira HL, Yamada ES, Neves BC, Pereira A Jr (2019) The gut and Parkinson\u2019s disease-a bidirectional pathway. Front Neurol 10:574. https:\/\/doi.org\/10.3389\/fneur.2019.00574","journal-title":"Front Neurol"},{"key":"3187_CR40","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/nutrit\/nuy009","volume":"76","author":"MH Mohajeri","year":"2018","unstructured":"Mohajeri MH, La Fata G, Steinert RE, Weber P (2018) Relationship between the gut microbiome and brain function. Nutr Rev 76:481\u2013496. https:\/\/doi.org\/10.1093\/nutrit\/nuy009","journal-title":"Nutr Rev"},{"issue":"1","key":"3187_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00415-017-8639-0","volume":"265","author":"R Erro","year":"2018","unstructured":"Erro R, Brigo F, Tamburin S, Zamboni M, Antonini A, Tinazzi M (2018) Nutritional habits, risk, and progression of Parkinson disease. J Neurol 265(1):12\u201323. https:\/\/doi.org\/10.1007\/s00415-017-8639-0","journal-title":"J Neurol"},{"key":"3187_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbi.2016.04.003","volume":"57","author":"A Houlden","year":"2016","unstructured":"Houlden A, Goldrick M, Brough D, Vizi ES, L\u00e9n\u00e1rt N, Martinecz B, Roberts IS, Denes A (2016) Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behav Immun 57:10\u201320. https:\/\/doi.org\/10.1016\/j.bbi.2016.04.003","journal-title":"Brain Behav Immun"},{"issue":"9","key":"3187_CR43","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1007\/s12035-018-0937-8","volume":"55","author":"P Garrido-Gil","year":"2018","unstructured":"Garrido-Gil P, Rodriguez-Perez AI, Dominguez-Meijide A, Guerra MJ, Labandeira-Garcia JL (2018) Bidirectional neural interaction between central dopaminergic and gut lesions in Parkinson\u2019s disease models. Mol Neurobiol 55(9):7297\u20137316. https:\/\/doi.org\/10.1007\/s12035-018-0937-8","journal-title":"Mol Neurobiol"},{"issue":"6","key":"3187_CR44","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3390\/ijms19061689","volume":"19","author":"V Caputi","year":"2018","unstructured":"Caputi V, Giron MC (2018) Microbiome-gut-brain axis and toll-like receptors in Parkinson\u2019s disease. Int J Mol Sci 19(6):1689. https:\/\/doi.org\/10.3390\/ijms19061689","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3187_CR45","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"JM Yano","year":"2015","unstructured":"Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY (2015) Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161(2):264\u2013276. https:\/\/doi.org\/10.1016\/j.cell.2015.02.047","journal-title":"Cell"},{"issue":"11","key":"3187_CR46","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1210\/jcem.82.11.4339","volume":"82","author":"G Eisenhofer","year":"1997","unstructured":"Eisenhofer G, \u00c5neman A, Friberg P, Hooper D, F\u00e5ndriks L, Lonroth H, Hunyady B, Mezey E (1997) Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab 82(11):3864\u20133871. https:\/\/doi.org\/10.1210\/jcem.82.11.4339","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3187_CR47","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, Mazmanian SK (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167(6):1469\u20131480. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018","journal-title":"Cell"},{"key":"3187_CR48","doi-asserted-by":"publisher","first-page":"109564","DOI":"10.1016\/j.mehy.2020.109564","volume":"137","author":"G Tern\u00e1k","year":"2020","unstructured":"Tern\u00e1k G, Kuti D, Kov\u00e1cs KJ (2020) Dysbiosis in Parkinson\u2019s disease might be triggered by certain antibiotics. Med Hypotheses 137:109564. https:\/\/doi.org\/10.1016\/j.mehy.2020.109564","journal-title":"Med Hypotheses"},{"key":"3187_CR49","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3389\/fnins.2019.00839","volume":"13","author":"AM Gorecki","year":"2019","unstructured":"Gorecki AM, Preskey L, Bakeberg MC, Kenna JE, Gildenhuys C, MacDougall G, Dunlop SA, Mastaglia FL, Akkari PA, Koengten F, Anderton RS (2019) Altered gut microbiome in Parkinson\u2019s disease and the influence of lipopolysaccharide in a human \u03b1-synuclein over-expressing mouse model. Front Neurosci 13:839. https:\/\/doi.org\/10.3389\/fnins.2019.00839","journal-title":"Front Neurosci"},{"issue":"9","key":"3187_CR50","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/mds.25522","volume":"28","author":"A Fasano","year":"2013","unstructured":"Fasano A, Bove F, Gabrielli M, Petracca M, Zocco MA, Ragazzoni E, Barbaro F, Piano C, Fortuna S, Tortora A, Di Giacopo R, Campanale M, Gigante G, Lauritano EC, Navarra P, Marconi S, Gasbarrini A, Bebtivoglio RA (2013) The role of small intestinal bacterial overgrowth in Parkinson\u2019s disease. J Mov Disord 28(9):1241\u20131249. https:\/\/doi.org\/10.1002\/mds.25522","journal-title":"J Mov Disord"},{"key":"3187_CR51","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","volume":"70","author":"MF Sun","year":"2018","unstructured":"Sun MF, Zhu YL, Zhou ZL, Jia XB, Xu YD, Yang Q, Cui C, Shen YQ (2018) Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway. Brain Behav Immun 70:48\u201360. https:\/\/doi.org\/10.1016\/j.bbi.2018.02.005","journal-title":"Brain Behav Immun"},{"issue":"1","key":"3187_CR52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"CH Lin","year":"2019","unstructured":"Lin CH, Chen CC, Chiang HL, Liou JM, Chang CM, Lu TP, Chuang EY, Tai YC, Cheng C, Lin HY, Wu MS (2019) Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J Neuroinflammation 16(1):129. https:\/\/doi.org\/10.1186\/s12974-019-1528-y","journal-title":"J Neuroinflammation"},{"issue":"5","key":"3187_CR53","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, Knight R, Payami H (2017) Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 32(5):739\u2013749. https:\/\/doi.org\/10.1002\/mds.26942","journal-title":"Mov Disord"},{"issue":"6","key":"3187_CR54","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/mds.1203","volume":"16","author":"R Hardoff","year":"2001","unstructured":"Hardoff R, Sula M, Tamir A, Soil A, Front A, Badarna S, Honigman S, Giladi N (2001) Gastric emptying time and gastric motility in patients with Parkinson\u2019s disease. J Mov Disord 16(6):1041\u20131047. https:\/\/doi.org\/10.1002\/mds.1203","journal-title":"J Mov Disord"},{"issue":"4","key":"3187_CR55","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1212\/wnl.42.4.726","volume":"42","author":"LL Edwards","year":"1992","unstructured":"Edwards LL, Quigley EM, Pfeiffer RF (1992) Gastrointestinal dysfunction in Parkinson\u2019s disease: frequency and pathophysiology. Neurology 42(4):726\u2013732. https:\/\/doi.org\/10.1212\/wnl.42.4.726","journal-title":"Neurology"},{"issue":"1","key":"3187_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s100720170061","volume":"22","author":"M Pierantozzi","year":"2001","unstructured":"Pierantozzi M, Pietroiusti A, Sancesario G, Lunardi G, Fedele E, Giacomini P, Frasca S, Galante A, Marciani MG, Stanzione P (2001) Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson\u2019s disease patients. Neurol Sci 22(1):89\u201391. https:\/\/doi.org\/10.1007\/s100720170061","journal-title":"Neurol Sci"},{"issue":"11","key":"3187_CR57","doi-asserted-by":"publisher","first-page":"e112330","DOI":"10.1371\/journal.pone.0112330","volume":"9","author":"H Hashim","year":"2014","unstructured":"Hashim H, Azmin S, Razlan H, Yahya NW, Tan HJ, Manaf MRA, Ibrahim NM (2014) Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson\u2019s disease. PLoS One 9(11):e112330. https:\/\/doi.org\/10.1371\/journal.pone.0112330","journal-title":"PLoS One"},{"issue":"2","key":"3187_CR58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3988\/jcn.2016.12.2.147","volume":"12","author":"G \u00c7amci","year":"2016","unstructured":"\u00c7amci G, O\u011fuz S (2016) Association between Parkinson\u2019s disease and Helicobacter pylori. J Clin Neurol 12(2):147\u2013150. https:\/\/doi.org\/10.3988\/jcn.2016.12.2.147","journal-title":"J Clin Neurol"},{"issue":"7766","key":"3187_CR59","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-019-1405-y","volume":"571","author":"D Matheoud","year":"2019","unstructured":"Matheoud D, Cannon T, Voisin A, Penttinen AM, Ramet L, Fahmy AM, Ducrot C, Laplante A, Bourque MJ, Zhu L, Cayrol R, Campion AL, McBride HM, Gruenheid S, Trudeau LE, Desjardins M (2019) Intestinal infection triggers Parkinson\u2019s disease-like symptoms in Pink1\u2013\/\u2013 mice. Nature 571(7766):565\u2013569. https:\/\/doi.org\/10.1038\/s41586-019-1405-y","journal-title":"Nature"},{"issue":"1","key":"3187_CR60","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","volume":"10","author":"SP van Kessel","year":"2019","unstructured":"van Kessel SP, Frye AK, El-Gendy AO, Castejon M, Keshavarzian A, van Dijk G, El Aidy S (2019) Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease. Nat Commun 10(1):310. https:\/\/doi.org\/10.1038\/s41467-019-08294-y","journal-title":"Nat Commun"},{"issue":"11","key":"3187_CR61","doi-asserted-by":"publisher","first-page":"e0187307","DOI":"10.1371\/journal.pone.0187307","volume":"12","author":"T Minato","year":"2017","unstructured":"Minato T, Maeda T, Fujisawa Y, Tsuji H, Nomoto K, Ohno K, Hirayama M (2017) Progression of Parkinson\u2019s disease is associated with gut dysbiosis: two-year follow-up study. PloS One 12(11):e0187307. https:\/\/doi.org\/10.1371\/journal.pone.0187307","journal-title":"PloS One"},{"issue":"2","key":"3187_CR62","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.neurobiolaging.2010.02.018","volume":"33","author":"AK Singh","year":"2012","unstructured":"Singh AK, Tiwari MN, Upadhyay G, Patel DK, Singh D, Prakash O, Singh MP (2012) Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood. Neurobiol Aging 33(2):404\u2013415. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.02.018","journal-title":"Neurobiol Aging"},{"key":"3187_CR63","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.neuroscience.2014.07.054","volume":"277","author":"SM O\u2019Mahony","year":"2014","unstructured":"O\u2019Mahony SM, Felice VD, Nally K, Savignac HM, Claesson MJ, Scully P, Woznicki J, Hyland NP, Shanahan F, Quigley EM, Marchesi JR, O\u2019Toole PW, Dinan TG, Cryan JF (2014) Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats. Neuroscience 277:885\u2013901. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.07.054","journal-title":"Neuroscience"},{"issue":"9356","key":"3187_CR64","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0140-6736(03)12489-0","volume":"361","author":"F Guarner","year":"2003","unstructured":"Guarner F, Malagelada JR (2003) Gut flora in health and disease. Lancet 361(9356):512\u2013519. https:\/\/doi.org\/10.1016\/S0140-6736(03)12489-0","journal-title":"Lancet"},{"issue":"7346","key":"3187_CR65","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nature09944","volume":"473","author":"M Arumugam","year":"2011","unstructured":"Arumugam M, Raes J, Pelletier E, Paslier LD, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Dor\u00e9 J, MetaHIT C, Antol\u00edn M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, Guedon E, Haimet F, Huber W, van Hylckama-Vlieg J, Jamet A, Juste C, Kaci G, Knol J, Lakhdari O, Layec S, Roux KL, M\u00e9rieux A, Minardi RM, M\u2019rini Muller C, Oozeer J, Parkhill R, Renault J, Rescigno P, Sanchez M, Sunagawa N, Torrejon S, Turner A, Vandemeulebrouck K, Varela G, Winogradsky E, Zeller Y, Weissenbach G, Ehrlich J, Bork SD P (2011) Enterotypes of the human gut microbiome. Nature 473(7346):174\u2013180. https:\/\/doi.org\/10.1038\/nature09944","journal-title":"Nature"},{"issue":"11","key":"3187_CR66","doi-asserted-by":"publisher","first-page":"e0142164","DOI":"10.1371\/journal.pone.0142164","volume":"10","author":"S Hasegawa","year":"2015","unstructured":"Hasegawa S, Goto S, Tsuji H, Okuno T, Asahara T, Nomoto K, Shibata A, Fujisawa Y, Minato T, Okamoto A, Ohno K, Hirayama M (2015) Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson\u2019s disease. PloS One 10(11):e0142164. https:\/\/doi.org\/10.1371\/journal.pone.0142164","journal-title":"PloS One"},{"issue":"1","key":"3187_CR67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40035-019-0175-7","volume":"8","author":"C Haikal","year":"2019","unstructured":"Haikal C, Chen QQ, Li JY (2019) Microbiome changes: an indicator of Parkinson\u2019s disease? Transl Neurodegener 8(1):38. https:\/\/doi.org\/10.1186\/s40035-019-0175-7","journal-title":"Transl Neurodegener"},{"key":"3187_CR68","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, B\u00fcrmann J, Fa\u00dfbender K, Schwiertz A, Sch\u00e4fer KH (2016) Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord 32:66\u201372. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.08.019","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"3187_CR69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, W\u00fcllner U (2017) Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med 9(1):39. https:\/\/doi.org\/10.1186\/s13073-017-0428-y","journal-title":"Genome Med"},{"key":"3187_CR70","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","volume":"1667","author":"F Hopfner","year":"2017","unstructured":"Hopfner F, K\u00fcnstner A, M\u00fcller SH, K\u00fcnzel S, Zeuner KE, Margraf NG, Deuschl G, Baines JF, Kuhlenb\u00e4umer G (2017) Gut microbiota in Parkinson disease in a northern German cohort. Brain Res 1667:41\u201345. https:\/\/doi.org\/10.1016\/j.brainres.2017.04.019","journal-title":"Brain Res"},{"key":"3187_CR71","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","volume":"70","author":"Y Qian","year":"2018","unstructured":"Qian Y, Yang X, Xu S, Wu C, Song Y, Qin N, Chen SD, Xiao Q (2018) Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease. Brain Behav Immun 70:194\u2013202. https:\/\/doi.org\/10.1016\/j.bbi.2018.02.016","journal-title":"Brain Behav Immun"},{"issue":"10","key":"3187_CR72","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM (2015) Colonic bacterial composition in Parkinson\u2019s disease. Mov Disord 30(10):1351\u20131360. https:\/\/doi.org\/10.1002\/mds.26307","journal-title":"Mov Disord"},{"issue":"3","key":"3187_CR73","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s13311-019-00719-2","volume":"16","author":"ZL Zhou","year":"2019","unstructured":"Zhou ZL, Jia XB, Sun MF, Zhu YL, Qiao CM, Zhang BP, Zhao LP, Yang Q, Cui C, Chen X, Shen YQ (2019) Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson\u2019s disease mice via gut microbiota and metabolites. Neurotherapeutics 16(3):741\u2013760. https:\/\/doi.org\/10.1007\/s13311-019-00719-2","journal-title":"Neurotherapeutics"},{"issue":"2","key":"3187_CR74","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12035-012-8291-8","volume":"46","author":"S Yadav","year":"2012","unstructured":"Yadav S, Dixit A, Agrawal S, Singh A, Srivastava G, Singh AK, Srivastava PK, Prakash O, Singh MP (2012) Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson\u2019s disease pathogenesis. Mol Neurobiol 46(2):495\u2013512. https:\/\/doi.org\/10.1007\/s12035-012-8291-8","journal-title":"Mol Neurobiol"},{"issue":"1","key":"3187_CR75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.apsb.2019.12.001","volume":"10","author":"SL Collins","year":"2020","unstructured":"Collins SL, Patterson AD (2020) The gut microbiome: an orchestrator of xenobiotic metabolism. Acta Pharm Sin B 10(1):19\u201332. https:\/\/doi.org\/10.1016\/j.apsb.2019.12.001","journal-title":"Acta Pharm Sin B"},{"issue":"263","key":"3187_CR76","doi-asserted-by":"publisher","first-page":"263ra158","DOI":"10.1126\/scitranslmed.3009759","volume":"6","author":"V Braniste","year":"2014","unstructured":"Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, T\u00f3th M, Korecka A, Bakocevic N, Ng LG, Kundu P, Gulyas B, Halldin C, Hultenby K, Nilsson H, Hebert H, Volpe BT, Diamond B, Pettersson S (2014) The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 6(263):263ra158. https:\/\/doi.org\/10.1126\/scitranslmed.3009759","journal-title":"Sci Transl Med"},{"issue":"5","key":"3187_CR77","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","volume":"17","author":"CJ Kelly","year":"2015","unstructured":"Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ, Wilson KE, Glover LE, Kominsky DJ, Magnuson A, Weir TL, Ehrentraut SF, Pickel C, Kuhn KA, Lanis JM, Nguyen V, Taylor CT, Colgan SP (2015) Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17(5):662\u2013671. https:\/\/doi.org\/10.1016\/j.chom.2015.03.005","journal-title":"Cell Host Microbe"},{"issue":"1","key":"3187_CR78","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1749-6632.2012.06553.x","volume":"1258","author":"S Pl\u00f6ger","year":"2012","unstructured":"Pl\u00f6ger S, Stumpff F, Penner GB, Schulzke JD, G\u00e4bel G, Martens H, Shen Z, G\u00fcnzel D, Aschenbach JR (2012) Microbial butyrate and its role for barrier function in the gastrointestinal tract. Ann NY Acad Sci 1258(1):52\u201359. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06553.x","journal-title":"Ann NY Acad Sci"},{"issue":"9","key":"3187_CR79","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1021\/pr700864x","volume":"7","author":"IK Yap","year":"2008","unstructured":"Yap IK, Li JV, Saric J, Martin FP, Davies H, Wang Y, Wilson ID, Nicholson JK, Utzinger J, Marchesi JR, Holmes E (2008) Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. J Proteome Res 7(9):3718\u20133728. https:\/\/doi.org\/10.1021\/pr700864x","journal-title":"J Proteome Res"},{"key":"3187_CR80","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","volume":"45","author":"MF Sun","year":"2018","unstructured":"Sun MF, Shen YQ (2018) Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s disease. Ageing Res Rev 45:53\u201361. https:\/\/doi.org\/10.1016\/j.arr.2018.04.004","journal-title":"Ageing Res Rev"},{"issue":"4","key":"3187_CR81","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1096\/fj.14-259598","volume":"29","author":"CS Reigstad","year":"2015","unstructured":"Reigstad CS, Salmonson CE III, Szurszewski JF, Linden JH, Sonnenburg DR, Farrugia JL, Kashyap G PC (2015) Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J 29(4):1395\u20131403. https:\/\/doi.org\/10.1096\/fj.14-259598","journal-title":"FASEB J"},{"issue":"3","key":"3187_CR82","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/gut.47.3.397","volume":"47","author":"JP Segain","year":"2000","unstructured":"Segain JP, de la Bl\u00e9ti\u00e8re DR, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blotti\u00e8re HM, Galmiche JP (2000) Butyrate inhibits inflammatory responses through NF\u03baB inhibition: implications for Crohn\u2019s disease. Gut 47(3):397\u2013403. https:\/\/doi.org\/10.1136\/gut.47.3.397","journal-title":"Gut"},{"key":"3187_CR83","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1053\/j.gastro.2010.01.053","volume":"138","author":"R Soret","year":"2010","unstructured":"Soret R, Chevalier J, De Coppet P, Poupeau G, Derkinderen P, Segain JP, Neunlist M (2010) Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology 138:1772\u20131782. https:\/\/doi.org\/10.1053\/j.gastro.2010.01.053","journal-title":"Gastroenterology"},{"key":"3187_CR84","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.neuroscience.2015.09.033","volume":"310","author":"S Liang","year":"2015","unstructured":"Liang S, Wang T, Hu X, Luo J, Li W, Wu X, Duan Y, Jin F (2015) Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience 310:561\u2013577. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.09.033","journal-title":"Neuroscience"},{"issue":"4","key":"3187_CR85","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.parkreldis.2015.02.004","volume":"21","author":"E Cassani","year":"2015","unstructured":"Cassani E, Barichella M, Cancello R, Cavanna F, Iorio L, Cereda E, Bolliri C, Maria PZ, Bianchi F, Cestaro B, Pezzoli G (2015) Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson\u2019s disease. Parkinsonism Relat Disord 21(4):389\u2013393. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.02.004","journal-title":"Parkinsonism Relat Disord"},{"key":"3187_CR86","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neulet.2018.12.021","volume":"696","author":"S Wang","year":"2019","unstructured":"Wang S, Li N, Zou H, Wu M (2019) Gut microbiome-based secondary metabolite biosynthetic gene clusters detection in Parkinson\u2019s disease. Neurosci Lett 696:93\u201398. https:\/\/doi.org\/10.1016\/j.neulet.2018.12.021","journal-title":"Neurosci Lett"},{"issue":"8","key":"3187_CR87","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.3390\/nu11081896","volume":"11","author":"C Boulos","year":"2019","unstructured":"Boulos C, Yaghi N, El Hayeck R, Heraoui GN, Fakhoury-Sayegh N (2019) Nutritional risk factors, microbiota and Parkinson\u2019s disease: what is the current evidence? Nutrients 11(8):1896. https:\/\/doi.org\/10.3390\/nu11081896","journal-title":"Nutrients"},{"issue":"1","key":"3187_CR88","doi-asserted-by":"publisher","first-page":"18621","DOI":"10.1038\/s41598-019-54039-8","volume":"9","author":"LS Bulmer","year":"2019","unstructured":"Bulmer LS, Murray JA, Burns NM, Garber A, Wemelsfelder F, McEwan NR, Hastie PM (2019) High-starch diets alter equine faecal microbiota and increase behavioural reactivity. Sci Rep 9(1):18621. https:\/\/doi.org\/10.1038\/s41598-019-54039-8","journal-title":"Sci Rep"},{"issue":"S01","key":"3187_CR89","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1055\/a-0681-6700","volume":"86","author":"I Csoti","year":"2018","unstructured":"Csoti I, Dresel C, Hauptmann B, M\u00fcller T, Redecker C, Warnecke T, W\u00fcllner U (2018) Nutritional aspects in Parkinson\u2019s disease: disease risk, dietary therapy and treatment of digestive tract dysfunction. Fortschr Neurol Psychiatr 86(S01):S34\u2013S42. https:\/\/doi.org\/10.1055\/a-0681-6700","journal-title":"Fortschr Neurol Psychiatr"},{"key":"3187_CR90","doi-asserted-by":"publisher","first-page":"110609","DOI":"10.1016\/j.nut.2019.110609","volume":"71","author":"EE Leo","year":"2020","unstructured":"Leo EE, Campos MR (2020) Effect of ultra-processed diet on gut microbiota and thus its role in neurodegenerative diseases. Nutrition 71:110609. https:\/\/doi.org\/10.1016\/j.nut.2019.110609","journal-title":"Nutrition"},{"key":"3187_CR91","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-019-09594-x","author":"V Mofid","year":"2019","unstructured":"Mofid V, Izadi A, Mojtahedi SY, Khedmat L (2019) Therapeutic and nutritional effects of synbiotic yogurts in children and adults: a clinical review. Probiotics Antimicrob Proteins. https:\/\/doi.org\/10.1007\/s12602-019-09594-x","journal-title":"Probiotics Antimicrob Proteins"},{"key":"3187_CR92","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3389\/fphar.2019.01366","volume":"10","author":"MLE Luisi","year":"2019","unstructured":"Luisi MLE, Lucarini L, Biffi B, Rafanelli E, Pietramellara G, Durante M, Vidali S, Provensi G, Madiai S, Gheri CF, Masini E, Ceccherini MT (2019) Effect of mediterranean diet enriched in high quality extra virgin olive oil on oxidative stress, inflammation and gut microbiota in obese and normal weight adult subjects. Front Pharmacol 10:1366. https:\/\/doi.org\/10.3389\/fphar.2019.01366","journal-title":"Front Pharmacol"},{"issue":"1","key":"3187_CR93","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1038\/s41598-018-25190-5","volume":"8","author":"D Ma","year":"2018","unstructured":"Ma D, Wang AC, Parikh I, Green SJ, Hoffman JD, Chlipala G, Murphy MP, Sokola BS, Bauer B, Hartz AMS, Lin AL (2018) Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice. Sci Rep 8(1):6670. https:\/\/doi.org\/10.1038\/s41598-018-25190-5","journal-title":"Sci Rep"},{"issue":"6","key":"3187_CR94","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/1028415X.2017.1294555","volume":"21","author":"P Perez-Pardo","year":"2018","unstructured":"Perez-Pardo P, Dodiya HB, Broersen LM, Douna H, van Wijk N, Lopes da Silva S, Garssen J, Keshavarzian A, Kraneveld AD (2018) Gut\u2013brain and brain\u2013gut axis in Parkinson\u2019s disease models: effects of a uridine and fish oil diet. Nutr Neurosci 21(6):391\u2013402. https:\/\/doi.org\/10.1080\/1028415X.2017.1294555","journal-title":"Nutr Neurosci"},{"issue":"12","key":"3187_CR95","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.4103\/1673-5374.241429","volume":"13","author":"S Filosa","year":"2018","unstructured":"Filosa S, Di Meo F, Crispi S (2018) Polyphenols-gut microbiota interplay and brain neuromodulation. Neural Regen Res 13(12):2055\u20132059. https:\/\/doi.org\/10.4103\/1673-5374.241429","journal-title":"Neural Regen Res"},{"issue":"1","key":"3187_CR96","doi-asserted-by":"publisher","first-page":"18625","DOI":"10.1038\/s41598-019-54461-y","volume":"9","author":"RP Weinberg","year":"2019","unstructured":"Weinberg RP, Koledova VV, Subramaniam A, Schneider K, Artamonova A, Sambanthamurthi R, Hayes KC, Sinskey AJ, Rha C (2019) Palm Fruit Bioactives augment expression of tyrosine hydroxylase in the nile grass rat basal ganglia and alter the colonic microbiome. Sci Rep 9(1):18625. https:\/\/doi.org\/10.1038\/s41598-019-54461-y","journal-title":"Sci Rep"},{"key":"3187_CR97","doi-asserted-by":"publisher","first-page":"102138","DOI":"10.1016\/j.anaerobe.2019.102138","volume":"61","author":"F Wu","year":"2020","unstructured":"Wu F, Guo X, Zhang M, Ou Z, Wu D, Deng L, Lu Z, Zhang J, Deng G, Chen S, Li S, Yi J, Peng Y (2020) An Akkermansia muciniphila subtype alleviates high-fat diet-induced metabolic disorders and inhibits the neurodegenerative process in mice. Anaerobe 61:102138. https:\/\/doi.org\/10.1016\/j.anaerobe.2019.102138","journal-title":"Anaerobe"},{"key":"3187_CR98","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neuro.2019.09.013","volume":"75","author":"P Roman","year":"2019","unstructured":"Roman P, Cardona D, Sempere L, Carvajal F (2019) Microbiota and organophosphates. Neurotoxicology 75:200\u2013208. https:\/\/doi.org\/10.1016\/j.neuro.2019.09.013","journal-title":"Neurotoxicology"},{"issue":"2","key":"3187_CR99","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1460-9568.2005.04220.x","volume":"22","author":"MM Iravani","year":"2005","unstructured":"Iravani MM, Leung CC, Sadeghian M, Haddon CO, Rose S, Jenner P (2005) The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation. Eur J Neurosci 22(2):317\u2013330. https:\/\/doi.org\/10.1111\/j.1460-9568.2005.04220.x","journal-title":"Eur J Neurosci"},{"issue":"12","key":"3187_CR100","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1089\/jmf.2014.7000","volume":"17","author":"L Galland","year":"2014","unstructured":"Galland L (2014) The gut microbiome and the brain. J Med Food 17(12):1261\u20131272. https:\/\/doi.org\/10.1089\/jmf.2014.7000","journal-title":"J Med Food"},{"issue":"1","key":"3187_CR101","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/nu8010056","volume":"8","author":"TA Jenkins","year":"2016","unstructured":"Jenkins TA, Nguyen JC, Polglaze KE, Bertrand PP (2016) Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients 8(1):56. https:\/\/doi.org\/10.3390\/nu8010056","journal-title":"Nutrients"},{"issue":"5","key":"3187_CR102","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.parkreldis.2014.02.019","volume":"20","author":"AH Tan","year":"2014","unstructured":"Tan AH, Mahadeva S, Thalha AM, Gibson PR, Kiew CK, Yeat CM, Ng SW, Ang SP, Chow SK, Tan CT, Yong HS, Marras C, Fox SH, Lim SY (2014) Small intestinal bacterial overgrowth in Parkinson\u2019s disease. Parkinsonism Relat Disord 20(5):535\u2013540. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.02.019","journal-title":"Parkinsonism Relat Disord"},{"key":"3187_CR103","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.parkreldis.2018.04.003","volume":"54","author":"JA Vizcarra","year":"2018","unstructured":"Vizcarra JA, Wilson-Perez HE, Fasano A, Espay AJ (2018) Small intestinal bacterial overgrowth in Parkinson\u2019s disease: tribulations of a trial. Parkinsonism Relat Disord 54:110\u2013112. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.04.003","journal-title":"Parkinsonism Relat Disord"},{"issue":"21","key":"3187_CR104","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","volume":"73","author":"R Savica","year":"2009","unstructured":"Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, Bharucha AE, Rocca WA (2009) Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology 73(21):1752\u20131758. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c34af5","journal-title":"Neurology"},{"issue":"2","key":"3187_CR105","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF01308169","volume":"37","author":"JF Johanson","year":"1992","unstructured":"Johanson JF, Sonnenberg A, Koch TR, Mccarty DJ (1992) Association of constipation with neurologic diseases. Digest Dis Sci 37(2):179\u2013186. https:\/\/doi.org\/10.1007\/BF01308169","journal-title":"Digest Dis Sci"},{"issue":"2","key":"3187_CR106","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3233\/JPD-160982","volume":"7","author":"T Mishima","year":"2017","unstructured":"Mishima T, Fukae J, Fujioka S, Inoue K, Tsuboi Y (2017) The prevalence of constipation and irritable bowel syndrome in Parkinson\u2019s disease patients according to Rome III diagnostic criteria. J Parkinsons Dis 7(2):353\u2013357. https:\/\/doi.org\/10.3233\/JPD-160982","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"3187_CR107","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5009\/gnl.2011.5.1.29","volume":"5","author":"HS Cho","year":"2011","unstructured":"Cho HS, Park JM, Lim CH, Cho YK, Lee IS, Kim SW, Choi MG, Chung IS, Chung YK (2011) Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut Liver 5(1):29\u201336. https:\/\/doi.org\/10.5009\/gnl.2011.5.1.29","journal-title":"Gut Liver"},{"issue":"8","key":"3187_CR108","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00406-014-0502-z","volume":"264","author":"G Fond","year":"2014","unstructured":"Fond G, Loundou A, Hamdani N, Boukouaci W, Dargel A, Oliveira J, Roger M, Tamouza R, Leboyer M, Boyer L (2014) Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 264(8):651\u2013660. https:\/\/doi.org\/10.1007\/s00406-014-0502-z","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"3187_CR109","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5056\/jnm17105","volume":"24","author":"AT Nair","year":"2018","unstructured":"Nair AT, Ramachandran V, Joghee NM, Antony S, Ramalingam G (2018) Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of Parkinson\u2019s disease: a critical review. J Neurogastroenterol Motil 24(1):30\u201342. https:\/\/doi.org\/10.5056\/jnm17105","journal-title":"J Neurogastroenterol Motil"},{"issue":"s2","key":"3187_CR110","doi-asserted-by":"publisher","first-page":"S297","DOI":"10.3233\/JPD-191711","volume":"9","author":"JM Boertien","year":"2019","unstructured":"Boertien JM, Pereira PA, Aho VT, Scheperjans F (2019) Increasing comparability and utility of gut microbiome studies in Parkinson\u2019s disease: a systematic review. J Parkinsons Dis 9(s2):S297\u2013S312. https:\/\/doi.org\/10.3233\/JPD-191711","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"3187_CR111","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jfma.2018.02.005","volume":"118","author":"WK Wu","year":"2019","unstructured":"Wu WK, Chen CC, Panyod S, Chen RA, Wu MS, Sheen LY, Chang SC (2019) Optimization of fecal sample processing for microbiome study-the journey from bathroom to bench. J Formos Med Assoc 118(2):545\u2013555. https:\/\/doi.org\/10.1016\/j.jfma.2018.02.005","journal-title":"J Formos Med Assoc"},{"issue":"10","key":"3187_CR112","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/s41591-018-0164-x","volume":"24","author":"Y He","year":"2018","unstructured":"He Y, Wu W, Zheng HM, Li P, McDonald D, Sheng HF, Chen MX, Chen ZH, Ji GY, Mujagond P, Chen XJ, Rong ZH, Chen P, Lyu LY, Wang X, Wu CB, Yu N, Xu YJ, Yin J, Raes J, Knight R, Ma WJ, Zhou HW (2018) Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nat Med 24(10):1532\u20131535. https:\/\/doi.org\/10.1038\/s41591-018-0164-x","journal-title":"Nat Med"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03187-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-020-03187-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03187-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T15:54:04Z","timestamp":1614095644000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-020-03187-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["3187"],"URL":"https:\/\/doi.org\/10.1007\/s11064-020-03187-9","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"25 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The Authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}